These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1313156)
1. The effect of benzodiazepines on the binding of [3H]SCH 23390 in vivo. Inoue O; Kobayashi K; Sakiyama Y; Suzuki T Neuropharmacology; 1992 Feb; 31(2):115-21. PubMed ID: 1313156 [TBL] [Abstract][Full Text] [Related]
2. In vivo binding of (3H)Ro 15-1788 in mice: comparison with the in vivo binding of (3H)flunitrazepam. Potier MC; Prado de Carvalho L; Dodd RH; Brown CL; Rossier J Life Sci; 1988; 43(16):1287-96. PubMed ID: 2845217 [TBL] [Abstract][Full Text] [Related]
3. Effects of the GABAergic system on in vivo binding of [3H]N-methylspiperone. Nakano T; Kobayashi K; Hosoi R; Wakahara S; Watanabe Y; Nishimura T; Inoue O Neuropharmacology; 1998; 37(3):375-81. PubMed ID: 9681935 [TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. Möhler H; Burkard WP; Keller HH; Richards JG; Haefely W J Neurochem; 1981 Sep; 37(3):714-22. PubMed ID: 6268754 [TBL] [Abstract][Full Text] [Related]
5. An increase in the in vivo binding of [3H]SCH 23390 induced by MK-801 in the mouse striatum. Kobayashi K; Inoue O Neuropharmacology; 1993 Apr; 32(4):341-8. PubMed ID: 8497337 [TBL] [Abstract][Full Text] [Related]
6. Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat. Kulkarni SK; Ticku MK Brain Res; 1990 Jun; 519(1-2):6-11. PubMed ID: 2168788 [TBL] [Abstract][Full Text] [Related]
7. Kinetic differences between type I and type II benzodiazepine receptors. Trifiletti RR; Lo MM; Snyder SH Mol Pharmacol; 1984 Sep; 26(2):228-40. PubMed ID: 6090882 [TBL] [Abstract][Full Text] [Related]
8. The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines. Concas A; Serra M; Santoro G; Maciocco E; Cuccheddu T; Biggio G Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):294-300. PubMed ID: 7824046 [TBL] [Abstract][Full Text] [Related]
9. Conformational changes in benzodiazepine receptors induced by the antagonist Ro 15-1788. Chiu TH; Rosenberg HC Mol Pharmacol; 1983 Mar; 23(2):289-94. PubMed ID: 6300640 [TBL] [Abstract][Full Text] [Related]
10. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors. Trifiletti RR; Snyder SH Mol Pharmacol; 1984 Nov; 26(3):458-69. PubMed ID: 6092896 [TBL] [Abstract][Full Text] [Related]
11. Increased binding of [3H]muscimol and [3H]flunitrazepam in the rat brain under hypoxia. Ninomiya H; Taniguchi T; Kameyama M; Fujiwara M J Neurochem; 1988 Oct; 51(4):1111-7. PubMed ID: 2843604 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS. Mehta AK; Shank RP Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro modulation of central type benzodiazepine receptors by phosphatidylserine. Levi de Stein M; Medina JH; De Robertis E Brain Res Mol Brain Res; 1989 Jan; 5(1):9-15. PubMed ID: 2538706 [TBL] [Abstract][Full Text] [Related]
14. Effect of diethyl pyrocarbonate modification of benzodiazepine receptors on [3H]Ro 15-4513 binding. Uusi-Oukari M J Neurochem; 1992 Aug; 59(2):560-7. PubMed ID: 1321230 [TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine receptors in human brain: characterization, subcellular localization and solubilization. Maloteaux JM; Octave JN; Vanisberg MA; Kollmann P; Ackermans A; Laterre C Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):773-82. PubMed ID: 2851861 [TBL] [Abstract][Full Text] [Related]
16. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine. Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566 [TBL] [Abstract][Full Text] [Related]
17. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599 [TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to Ro 15-1788: differential effect on flunitrazepam binding to cortex and hippocampus. Urbancic M; Marczynski TJ Eur J Pharmacol; 1989 Nov; 171(1):1-7. PubMed ID: 2515067 [TBL] [Abstract][Full Text] [Related]
19. [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs. Koe BK; Kondratas E; Russo LL Eur J Pharmacol; 1987 Oct; 142(3):373-84. PubMed ID: 2892685 [TBL] [Abstract][Full Text] [Related]
20. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats. Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]